We hypothesize that T cells such as interleukin (IL) 
Introduction
Current immunosuppressive regimens in renal transplantation are directed primarily against T cell-mediated alloimmunity. However, many allograft recipients still develop allograft rejection through both T cell-mediated and/or antibody-mediated alloimmune responses [1, 2] . Allograft rejection is a consequence of the activation of the recipient's immune system and includes the interaction between T and B cells via antigen presentation, co-stimulation and cytokine production. The local interaction in the renal allograft between T and B cells and its potential contribution to graft damage is still debated [3] . Recent studies by Loupy et al. [4] and Halloran et al. [5] plea for a key role for T cells in the mechanism leading to chronic allograft rejection, traditionally the outcome of B cell-mediated immunity. Thus, studying the presence, organization and functional hallmarks of T and B cells within grafts of acute renal allograft rejection is essential for gaining a better understanding of the in-situ immunological interactions in renal allograft rejection.
The formation of antibodies is a result of the interaction between T follicular helper (Tfh) cells and B cells [6] . This Tfh-B cell interaction is complex and involves various activation and regulatory pathways, including interleukin (IL)-21 signalling [6, 7] . Activated Tfh and B cells reside in germinal centres (GCs) and both express transcriptional repressor B cell lymphoma 6 (BCL6). Expression of BCL6 is essential for GC maintenance and BCL6 represses transcription factors of other lymphocyte subsets [8] . The organized structure of the GC -a T cell zone surrounding the active centre where B cells and follicular dendritic cells (FDCs) reside -is crucial for correct B cell affinity maturation [9] . After antigen recognition, Tfh cells initiate the differentiation of B cells into antibody-producing plasma cells via secretion of IL-21 [10] . The maintenance of the GCs as part of secondary lymphoid organs (SLOs) is preserved by the presence of FDC networks [11] . These FDC networks are involved in antigen priming of T cells and stimulation of B cell affinity selection and maturation. Antigendependent Tfh-B cell interaction and GC formation takes place primarily in SLOs, such as draining lymph nodes. However, chronic persistence of antigen leads to the formation of highly organized leucocyte aggregates that resemble SLOs. These ectopic lymphoid structures (ELSs), also called tertiary lymphoid organs (TLOs), initiate antigen-specific responses locally, i.e. at the site of the antigen [12] . The formation of ELSs has been recognized in inflamed tissue caused by infection, autoimmunity and cancer [12] . In organ transplantation ELSs are associated mainly with chronic rejection, although these structures are also recognized in acute renal allograft rejection [13] [14] [15] . In 2003 Sarwal et al. [13] described the presence of CD20
1 B cell clusters in kidneys of renal transplant patients with acute rejection. The potential functions of these T and B cells in ELSs in acute renal allograft rejection and in which types of acute renal rejection these ELSs are particularly formed is largely unknown.
To understand more clearly the pathophysiology of rejection after organ transplantation we studied the organization of T and B cells with respect to GC features (i.e. positive for FDCs, IgD (indicating active Ig production), Ki67 (indicating proliferation) and co-localization of BCL6 and IL-21) [16] in human renal allografts with acute rejection. To assess whether T cells regulate B cell-mediated immunity within the grafts of T cell-mediated rejection, we studied for the first time the presence of these structures in various categories of acute rejection: acute T cell-mediated rejection grade I (aTCMRI), acute T cell-mediated rejection grade II (aTCMRII) and acute/active antibody-mediated rejection (a/aABMR). Improved characterization of the immunological features of the ELSs in the renal allograft may provide a deeper understanding of the mechanisms underlying different types of acute rejection.
Materials and methods

Patient population
In this retrospective study we analysed a total of 15 renal transplant biopsies from 15 different patients with an acute allograft rejection. The patients were selected based upon the primary rejection diagnosis based on routine histopathological stainings. The primary diagnoses were acute/active antibody-mediated rejection (a/aABMR, n 5 5) in which, according to the Banff, C4d was positive and donor-specific antigens (DSA) were present; acute T cell-mediated rejection grade I (aTCMRI, n 5 5) and acute T cell-mediated rejection grade II (aTCMRII, n 5 5). The different pathological Table 2 as aggregates. Cropped images represent an aggregate in the acute T cell-mediated rejection grade I (aTCMRI) and a more diffuse cellular infiltrate in the aTCMRII. a/aABMR 5 acute/active antibody-mediated rejection; aTCMRI 5 acute T cell-mediated rejection grade I; aTCMRII 5 acute T cell-mediated rejection grade II. Yes  3  3  2  2  1  1  1  2  1  3  Yes  2  2  1  1  1  3  2  3  1  4  Yes  2  2  1  1  1  1  1  3  1  5  Yes  3  3  3  3  2  3  1  3  2  aTCMR II  1  Yes  3  3  3  0  0  0  1  1  0  2  N o  3  3  0  0  1  0  1  1  0  3  No  3 
Immunohistochemical stainings
All renal biopsies were formalin-fixed and paraffinembedded (FFPE). Biopsies were processed according to a standardized diagnostic protocol. For histomorphological assessment, 3-mm sections were cut and stained with haematoxylin and eosin (H&E), periodic acid-schiff (PAS) and Jones' silver stain. In addition, an immunohistochemical C4d staining was performed on a 4-mm paraffin section. Subsequently, immunohistochemical stainings were performed on the Benchmark Ultra Stainer (Ventana, Basel, Switzerland). The following ready-to-use monoclonal antibodies (mAbs) were used: CD3 (Ventana; ref. 0 -diaminobenzidine (DAB) was used as chromogen. Sections were counterstained with haematoxylin. The quantification method used for these stainings was based on a numerical scale ranging from negative (0) to severe (3). High-power fields (HPF) with 0-25 positive cells were scored as mild (1), 26-100 positive cells were scored as moderate (2) and > 100 positive cells were scored as severe (3) . When biopsy material on the slide was insufficient we did not score and noted the staining as not applicable (n.a.).
Immunofluorescence
Four-mm FFPE sections were deparaffinized up to 100% ethanol (EtOH). Endogenous peroxidase was blocked for 10 min in 0Á5% H 2 O 2 in methanol. Afterwards, sections were heated in a microwave in a Tris-ethylenediamine tetraacetic acid (EDTA) buffer to obtain antigen retrieval. In order to bypass non-specific antibody binding, sections were incubated for 30 min with 10% human serum and Fig. S1 ). Images were taken and double-blind scoring on the images was performed in the presence of single-and doublepositive cells with a ranked scale ranging from negative (0) to severe (3) presence of positive cells.
Results
Organized ELSs present predominantly in aTCMRI
All 15 renal rejection biopsies were stained with H&E to assess cellular infiltrates within the renal allograft (a representative example is shown in Fig. 1 ). In total, six of 15 biopsies (40%) contained dense cellular aggregates. Remarkably, cellular aggregates were detected in four of five aTCMRI biopsies (80%) (black arrows, Fig. 1, Table 2 ). In contrast, only one of five biopsies (20%) in both the aTCMRII and a/aABMR groups contained cellular aggregates ( Table 2) .
Analyses of the immunohistochemical stainings are depicted in Table 2 and representative examples are presented in Figs 2 and 3. In all 15 biopsies, diffuse cellular Stainings were performed in three types of renal allograft rejection: acute/active antibody-mediated rejection (a/aABMR), acute T cell-mediated rejection grade I (aTCMRI) and aTCMRII. Magnification: a/aABMR and aTCMRII 320, aTCMRI 310. aTCMRI biopsies were analysed with a lower magnification than the a/aABMR and aTCMRII biopsies in order to visualize the complete aggregate structures.
infiltrates of CD3
1 T cells were detected in the tubulointerstitial compartment and CD4 1 cells were present, which might be a mixture of CD4 1 T cells and monocytes (Fig. 2 , Table 2 ) [18, 19] . Within the aTCMRI biopsies, with aggregate formation, the T cells formed clear clusters compared to a more diffuse localization of T cells in the biopsies with aTCMRII or a/aABMR (Fig. 2) . As expected, biopsies showing a/aABMR only had moderate to mild infiltration of T cells in contrast to extensive T cell infiltration in the biopsies with either aTCMRI or aTCMRII. CD20 1 B cells were detected in a diffuse manner in four of five a/aABMR biopsies (80%) and three of five aTCMRII biopsies (60%). In contrast, all biopsies with aTCMRI revealed a moderate to severe presence of B cells, which on consecutive sections co-localized with the T cell infiltrates (Fig. 2) , representing a B and T cell architecture of an ELS. In addition, five of six biopsies with aggregates (83%) showed the presence of CD23-positive FDC networks, four of which (80%) were biopsies with an aTCMRI. The FDCs formed clear networks in the centre of the B and T cell aggregates, with overlap with the B cell nodules (Fig. 2) . In terms of activation, a subset of the B cells was positive for CD79A in all biopsies with aTCMRI, demonstrating an activated B cell phenotype, until differentiation to plasma cells (Fig. 3 ) [20] . The presence of IgD in all aTCMRI biopsies -mainly within the aggregates -confirmed local immunoglobulin production supporting a GC reaction (Fig. 3) . In all aTCMRI biopsies Ki67 1 cells were present pointing towards active structures with proliferating cells. As expected, in the aTCMRII biopsies infiltrating cells stained positive for Ki67 due to the high number of infiltrating cells in this type of rejection. In contrast, the majority of the a/aABMR stained negative for Ki67. The follow-up of renal graft function after the rejection episode revealed that the patients with aTCMRI biopsies positive for T cells, B cells, FDC networks and IgD did not present differences in graft function at 3 months after the rejection biopsy compared to the other patients (Table 3) .
Co-localization of BCL6 and IL-21 in ELSs
Simultaneous staining for BCL6 and IL-21 was performed to determine GC features. IL-21 1 cells were found in all biopsies. Within the aggregates, the majority of cells were IL-21 1 , whereas outside the aggregates and in biopsies without aggregates, lower numbers of IL-21 1 cells were found. Co-localization of IL-21 and BCL6 expression was observed predominantly within the B and T cell aggregates (Fig. 4) in the aTCMRI biopsies (Table 2 ).
Discussion
T and B cell aggregates are formed locally in the renal allograft upon persistent alloantigen exposure [3, 7, 13] . The role of these aggregates in alloreactivity is still debated. A growing body of evidence suggests that these structures are also present in more acute responses in which T cells are dominating [21] . Here, we characterized lymphoid aggregates present in renal allografts and describe for the first time, to our knowledge, differences in the composition and formation of ELSs among three types of renal allograft rejection, namely aTCMRI, aTCMRII and a/aABMR. We found that organized lymphoid aggregates are present mainly in biopsies diagnosed as aTCMRI. We believe these represent active ELSs with FDC networks, IgD and BCL6 1 IL-21 1 cells, possibly Tfh cells, that provide B cell help. B cells were found in all biopsies in which aggregates were seen. In accordance with previous work by Sarwal et al. [13] and de Graav et al. [15] , high numbers of B cells were found in biopsies showing aTCMRI. The role of these intragraft B cell infiltrates is debated. Some studies have found that B cell clusters are associated with poorer graft outcomes [22, 23] , whereas other studies did not find an association between CD20
1 B cell infiltrates and graft survival [24] [25] [26] . The presence of B cells in combination with FDC networks, IgD and Ki67 suggests humoral activity, including the production of antibodies. However, all cases of aTCMRI were negative for C4d and DSA. Although it is possible that these B cells produced donor-specific nonhuman leucocyte antigen (HLA) antibodies, we believe that this is not the most likely explanation, as such antibodies are rare. B cell infiltrates in the setting of aTCMRI more probably have an antibody-independent function. B cells are known for their antigen-presenting capacity that may facilitate T cell-mediated alloreactivity and aTCMRI. From mouse studies we know that antigen presentation by B cells indeed contributes to acute T cell-mediated rejection [27, 28] . In addition, B cells may also contribute to T cell activation via the secretion of cytokines such as interferon (IFN)-g, IL-10, tumour necrosis factor (TNF) and IL-6 [29] . Another hypothesis is that the clustered, intragraft B cells found in aTCMRI have a resting phenotype. However, all aTCMRI biopsies were double-positive for BCL6 and IL-21, markers associated with an activated state of Tfh cells and B cells. Finally, in different mouse models ELSs are also associated with donor-specific tolerance rather than rejection [30, 31] , suggesting that the B cells may have a regulatory function. The presence of transitional CD19 1 CD24 hi CD38 hi B cells, also known as regulatory B cells, is associated with lower acute rejection rates after renal transplantation [32] [33] [34] . In addition, in a mouse model for multiple sclerosis, maturation of regulatory B cells requires IL-21 and CD40 interaction with T cells [35] , both present in ELSs in our aTCMRI biopsies. In our study, analysing biopsy specimens from patients, the function of the aggregates in aTCMRI renal allografts has not been determined. Although given that aTCMRI is considered to be less detrimental to the graft than the other rejection types it is tempting to speculate that these aggregates might have a resting or regulatory function rather than a harmful one. In contrast, in the long term, T cell-dependent activation of B cells within the allograft may contribute to the process of chronic allograft rejection.
All aggregates contained numerous IL-21 single-positive cells, of which only a few were positive for BCL6, the hallmark of GC Tfh cells and B cells. The presence of BCL6 1 IL-21 1 cells in the aggregates in combination with Ki67 positivity points towards GC activity and suggests the presence of activated Tfh cells. In addition to B cell help, the IL-21-positive T cells in aTCMRI might also enhance IFN-g production and cytotoxic activity of CD8 1 effector T cells, as observed in an allogeneic system by Kasaian et al. [36] . Another possibility is that the IL-21 single-positive cells represent Th17 cells that are known to be involved in ELS formation [37, 38] . In the biopsies with either aTCM-RII or a/aABMR, a diffuse presence of T and B cells was observed and no FDC networks, IgD and co-localization of BCL6 and IL-21 was present in the majority of the cases. These findings suggest that the peripheral DSA present in the a/aABMR cases were not produced locally but outside the allograft (e.g. in draining lymph nodes). The effect of the presence of ELSs on renal allograft outcome is debated, with conflicting data that present both harmful and protective function. A recent study by Xu et al. [39] found an association between the presence of ELSs and wellfunctioning kidney grafts pointing towards a regulatory role for these ELSs. The small number of samples in this study does not allow us to draw conclusions concerning the impact of ELSs upon kidney function and warrant further investigation.
In this study, we focused upon T-B cell interaction and their functional activation markers in different types of acute renal allograft rejection. We found organized lymphoid structures in aTCMRI, implicating an important role for T and B cell interactions in this type of renal allograft rejection. Apparently, more cells are involved in aTCMRI than meets the eye, with presumably more mechanisms occurring than the classical alloreactive CD8
1 T cell infiltrates, such as providing help to alloactivated B cells. In conclusion, various compositions of infiltrating lymphocytes are present in the setting of aTCMRI, aTCMRII and a/aABMR with ELS formation predominantly in aTCMRI. These findings suggest a direct pathway of B cell alloactivation at the graft site during aTCMRI.
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